Skip to main content
. 2022 May 6;17(5):e0267715. doi: 10.1371/journal.pone.0267715

Fig 1.

Fig 1

Overall survival (A) and mortality (B) of patients with MAS within 6 months MAS: Macrophage activation syndrome, AOSD: Adult-onset still’s disease, SLE: Systemic lupus erythematosus.